Aberdeen Wealth Management LLC Bristol Myers Squibb CO Transaction History

Aberdeen Wealth Management LLC

$166 Million
Q1 2024

A detailed history of Aberdeen Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 6,919 shares of BMY stock, worth $284,509. This represents 0.23% of its overall portfolio holdings.

Number of Shares

6,919

Previous 6,919 -0.0%

Holding current value

$284,509

Previous $355,000 5.63%

% of portfolio

0.23%

Previous 0.27%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $24,240 - $28,925	-500 Reduced 6.74%	6,919 $355,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $5,789 - $6,473	-100 Reduced 1.33%	7,419 $430,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $1,274 - $1,414	20 Added 0.27%	7,519 $480,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $29,048 - $31,992	-400 Reduced 5.06%	7,499 $577,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1,072 - $1,250	20 Added 0.25%	7,899 $493,000

Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $40,413 - $47,338	-683 Reduced 7.98%	7,879 $466,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $15,369 - $17,285	-259 Reduced 2.94%	8,562 $541,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $11,778 - $13,347	204 Added 2.37%	8,821 $547,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $63,919 - $70,831	-1,113 Reduced 11.44%	8,617 $520,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $58,273 - $68,127	1,063 Added 12.26%	9,730 $572,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $6,960 - $10,114	-150 Reduced 1.7%	8,667 $483,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $433,884 - $565,963	8,817 New	8,817 $566,000

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.

Account

Aberdeen Wealth Management LLC Bristol Myers Squibb CO Transaction History